After almost three years of the pandemic, Severe Acute Respiratory Syndrome Coronavirus
2 (SARS-CoV-2) is still spreading around the world, causing notable sanitary and social …

Background Molnupiravir, an orally administered prodrug of the broadly active, direct-acting
antiviral, ribonucleoside analogue ß-d-N4-hydroxycytidine (NHC) is a promising COVID-19 …

COVID-19 merupakan penyakit infeksi yang disebabkan virus SARS-CoV-2 yang
dideklarasikan sebagai pandemik global pada tanggal 11 Maret 2020. COVID-19 dapat …

The efficiency of excited-state interaction between Sm3+ and the industrial product
Favipiravir (Fav) has been studied in different solvents and various pH values. The results …

After the identification of the SARS-CoV-2 virus, researchers have broadly studied different
medications that could be used to treat COVID-19 infections in order to reduce severity of …

Die von SARS-CoV-2 ausgelöste Erkrankung COVID-19 führte seit dem erstmaligen
Auftreten in Wuhan 2019 zu einer anhaltenden Pandemie und bisher mehreren Millionen …

Resultados: Mediante análisis realizados así como también mediante los resultados
obtenidos por las diferentes revisiones bibliográficas se ha podido determinar que el …

Resultados A través de los análisis realizados así como a través de los resultados
obtenidos por las diferentes revisiones bibliográficas se ha podido determinar que …

ABSTRACT ß-d-N4-hydroxycytidine (NHC), the parent nucleoside of molnupiravir, a COVID-
19 antiviral, was quantified at sites of SARS-CoV-2 transmission in twelve patients enrolled …

In the first stage of viral replication, Covid-19 may cause a remarkable inflammatory
response in patients. Molnupiravir is an oral antiviral medicine which functions through …